3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Head and Neck Neoplasms
2
Zollinger-Ellison Syndrome
1
Thrombosis
1
Thromboembolism
1
Stomach Ulcer
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Ischemic Stroke
1
Esophagitis, Peptic
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
apixaban
5
Enoxaparin
4
Dalteparin
4
Warfarin
2
Rivaroxaban
2
Injections
2
Heparin, Low-Molecular-Weight
2
Aspirin
2
salicylhydroxamic acid
1
palbociclib
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
X-Rays
1
Tinzaparin
1
Technetium Tc 99m Sulfur Colloid
1
Simvastatin
1
Saline Solution
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Musculoskeletal Manipulations
1
Hydroxyurea
1
Heparin
1
Fondaparinux
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thrombosis
×
Clopidogrel
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled